Showing results (1591-1600 of 4,521) with videos related to

Sort By:
Pageof 453
Future Oncology (London, England)|February 9, 2019
Serotonin levels and 1-year mortality in patients with neuroendocrine tumors: a systematic review and meta-analysisVijay N Joish, Sandip Shah, Jonothan C Tierce, et al.
Future Oncology (London, England)|February 9, 2019
KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancerKen Kato, Manish A Shah, Peter Enzinger, et al.
Future Oncology (London, England)|January 29, 2019
Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationaleViktor Grünwald, Thomas Powles, Toni K Choueiri, et al.
Future Oncology (London, England)|January 19, 2019
Role of osimertinib in the treatment of EGFR-mutation positive non-small-cell lung cancerJennifer W Carlisle, Suresh S Ramalingam
Future Oncology (London, England)|January 10, 2019
Bone metastases and skeletal-related events: incidence and prognosis according to histological subtype of lung cancerGustavo T Silva, Larissy M Silva, Anke Bergmann, et al.
Future Oncology (London, England)|December 5, 2018
Treatment patterns and outcomes among patients with recurrent/metastatic squamous cell carcinoma of the head and neckEric Nadler, Seongjung Joo, Marley Boyd, et al.
Future Oncology (London, England)|March 16, 2018
The role of IDH mutations in acute myeloid leukemiaGuillermo Montalban-Bravo, Courtney D DiNardo
Future Oncology (London, England)|December 8, 2018
XPG polymorphisms and their association with lung cancer susceptibility, overall survival and response in North Indian patients treated with platinum-based doublet chemotherapyShweta Lawania, Navneet Singh, Digambar Behera, et al.
Future Oncology (London, England)|December 14, 2018
Targeted eradication of gastric cancer stem cells by CD44 targeting USP22 small interfering RNA-loaded nanoliposomesFeng Yang, Zhi Zheng, Xuchao Xue, et al.
Future Oncology (London, England)|December 1, 2018
Hydration requirements in patients receiving highly emetogenic chemotherapyRandy Erickson, Neil Nebughr, Michael C Mosier, et al.
Pageof 453